Applying AI-ECG Solutions to Expand Clinical Utility
Offering the promise of early detection, enhanced interpretation, and the potential for improved patient care through clinically validated AI-ECG algorithms.
Heart disease represents the most significant disease burden and cost in healthcare and is the leading cause of death. The major challenge is early identification, as heart disease is only generally symptomatic at an advanced stage.
Artificial Intelligence-Enhanced Electrocardiography (AI-ECG) offers the opportunity to improve cardiovascular screening and enhance detection of heart disease. The electrical signal of the heart is rich in information that cannot be seen by the human eye. AI enables analysis of this hidden data and creation of detection algorithms.
MyoVista Insights Platform
Cloud-based, device-agnostic platform delivering AI-ECG algorithms across 12-lead ECG devices from major manufacturers. Seamlessly integrates with EHR systems for instant results.
- Device agnostic - works with existing ECG equipment
- Instant cloud-based processing
- SaaS model - pay only for what you use
- Secure, HIPAA-compliant infrastructure
MyoVista® wavECG™ Device
Full-featured 12-lead resting ECG hardware with built-in AI-ECG analysis. Portable, intuitive, and software upgradable to incorporate future algorithms.
- AI-ECG impaired cardiac relaxation algorithm
- Glasgow interpretative analysis
- Standard AHA/IEC lead placement
- Advanced Continuous Wavelet Transform processing
AI-ECG Algorithm Portfolio
Regulatory-compliant AI models from leading research partners. Our AI-ECG marketplace hosts partner algorithms for comprehensive cardiac screening.
Pre-FDA Submission
Low Ejection Fraction
Screening for reduced left ventricular ejection fraction using AI-ECG analysis.
Preserved Ejection Fraction
Screening for preserved ejection fraction conditions.
Impaired Cardiac Relaxation
Screening for diastolic dysfunction associated with hypertension and diabetes.
In Development
MyoVista Insights Platform
Cloud-based, hardware-agnostic platform delivering AI-ECG algorithms across 12-lead ECG devices from major manufacturers. Seamless EHR integration enables AI-enhanced cardiac screening at scale.
- Device agnostic - works with existing ECG equipment
- Instant results with cloud processing
- SaaS model - pay only for what you use
Ready to Enhance Your Cardiac Screening?
Request a demo to see how HeartSciences AI-ECG technology can enhance early detection of heart disease in your practice or health system.
Clinical Evidence Review
Walk through our 23 peer-reviewed publications and clinical validation data.
Platform Demonstration
See the MyoVista Insights cloud platform and device integration in action.
Implementation Planning
Discuss integration with your clinical workflows and EHR systems.